The European Commission has given the green light to the Dutch government’s €2 billion investment in the Pallas project, comprising a research reactor and a nuclear health center in Petten.
This approval complies with EU rules on state aid, ensuring that the project can go ahead without major distortions of competition.
The Pallas reactor will replace the existing High Flux Reactor (HFR), which has been in service since 1960.
Initially used for testing nuclear materials, the HFR has become essential for fundamental research and the production of medical radioisotopes, supplying 60% of Europe’s and 30% of the world’s needs for…
